Navigation Links
Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
Date:10/15/2007

eting represents only a portion of the totality of data that the Company has submitted to the FDA.

"Additional treatment options are important for the millions of U.S. women experiencing hot flashes and night sweats associated with menopause," says David F. Archer, lead investigator of the 12-week study and professor in the Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Clinical Research Center, Norfolk, Virginia. "Vasomotor symptoms can be quite disruptive for women in performing their daily activities. The study findings presented show that desvenlafaxine significantly reduced the number of hot flashes in postmenopausal women, and thus, if approved, may be an important treatment option."

About the Posters

Below are summaries of three separate analyses of the 12-week, multicenter, randomized, double-blind, placebo-controlled study. Postmenopausal women (N=458) with 50 or more moderate to severe hot flashes per week received either desvenlafaxine 100 mg/day, 150 mg/day or placebo. In addition, also presented was a secondary analysis of a previously presented 52-week study with desvenlafaxine.

Poster 412: Archer D., et al. Desvenlafaxine Succinate Efficacy for the Relief of Vasomotor Symptoms Associated With Menopause: A Double-Blind, Placebo-Controlled Trial

The analysis of the 12-week trial showed that desvenlafaxine 100 mg significantly reduced the frequency of moderate to severe hot flashes by 65 percent from baseline to the end of the trial, compared to a 51 percent reduction for placebo. This reduction in frequency of hot flashes with desvenlafaxine 100 mg was seen beginning at week one. The severity of hot flashes also reduced significantly at all time points compared to placebo among postmenopausal women who received desvenlafaxine.

Poster 421: Farmer M., et al. Safety and Tolerability of Desvenlafaxine Succinate in a Double-Blind, Placebo-Controlled Trial for the Relief of Vasomotor Symptoms Asso
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
2. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
3. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
4. RT-PCR Primers for the Study of Apoptosis
5. A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7 Cell Lines
6. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
7. New Fusion Trans-Activator Plasmids for Studying Signal Transduction Pathways
8. Medical College receives $377K to study brain disease
9. Kauffman study shows consistent entrepreneurial growth
10. Study affirms information technology-productivity link
11. Deltanoid Pharmaceuticals begins phase II osteoporosis study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014) The yield so far is small, ... a low-energy, solution-based mineral substitution process to make a ... in electronics and alternative energy devices. , A paper ... the July 21 issue of the journal Inorganic ... in the inorganic and nuclear chemistry fields. The paper ...
(Date:7/21/2014)... ALBANY, New York , July 21, 2014 ... up-to-date research on Global & USA ... Market Size, Trends, and Forecasts ResearchMoz ... USA  Cancer Biomaker Market   to 2018 (Identification, Technologies, ... Strategies, Industry Trends, and Pipeline Analysis. ...
(Date:7/20/2014)... the process releases radioactive krypton and xenon gases. Naturally ... gas radon. A new porous material called CC3 effectively ... Nature Materials shows how: by breathing enough ... , The CC3 material could be helpful in removing ... air in buildings and also in recycling useful elements ...
(Date:7/19/2014)... July 20, 2014 United States ... , GlobalDatas new report, "United States Non-Vascular Stents ... on the United States Non-Vascular Stents market. The ... volume (in units) and average prices (in US ... Biliary Stents and Metal Biliary Stents (Metal Non-Covered ...
Breaking Biology Technology:Oregon chemists eye improved thin films with metal substitution 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6A noble gas cage 2A noble gas cage 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4
... SHANGHAI, China, April 30 /Xinhua-PRNewswire/ -- Today, ... and NovaSecta in,their CRO Service Alliance CROSA ... companies. Tigermed,s expertise in clinical,development complements the ... the alliance., Sundia Meditech, United PharmaTech, ...
... add ... ... TSX symbol: SBS, CALGARY, April 30 /PRNewswire-FirstCall/ - Botaneco, a wholly-owned,subsidiary ... Croda Enterprise Technology, part of Croda,International Plc, an international manufacturer of speciality ingredients,with ...
... For-Profit Healthcare Companies, EL SEGUNDO, Calif., April ... care services, announced it has been honored for,the ... of the Top 125,ranking companies of employee-sponsored workforce ... that demonstrate a deep,commitment to learning and development ...
Cached Biology Technology:Shanghai CRO Service Alliance Adds Clinical Development Capabilities 2Shanghai CRO Service Alliance Adds Clinical Development Capabilities 3Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 2Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 3DaVita Honored for 4th Year as Training Top 125 Recipient 2
(Date:7/21/2014)... often results from the strength of immune response, rather ... rather than attacking the virus, might be a better ... the University of Washington, Seattle. She and her collaborators ... that for the H7N9 influenza, and their work has ... this highly virulent strain. The research is published ahead ...
(Date:7/21/2014)... Urban stormwater runoff is causing problems for the ... Environmental Protection Agency found stormwater runoff to be ... environments in rivers, streams, lakes, ponds, reservoirs, bays, ... can harm fish and wildlife populations, foul drinking ... from North Carolina State University are looking to ...
(Date:7/21/2014)... of life are now being developed to try and ... of species. Specifically, a recent model proposed by Petri ... accounts for species interactions with various degrees of symmetry, ... previous, simpler models, which apply random fitness levels to ... demonstrate that the resulting replicator ecosystems do not appear ...
Breaking Biology News(10 mins):Potential new flu drugs target immune response, not virus 2Filter bed substrates, plant types recommended for rain gardens 2Refined biological evolution model 2
... Data publishers should have the option of submitting their ... paper commissioned by the Global Biodiversity Information Facility (GBIF). ... recommendations made by Mark Costello and co-authors in the ... biodiversity data publication , freely available for download ...
... cells from patients with inherited heart muscle disease can ... to patients, including the possibility of testing new treatments ... cell model matches that of the clinical features of ... disease associated with sudden cardiac death Landmark study published ...
... more than 6,000 species of frogs in the world lay ... eggs out of water. This behavior protects the eggs from ... their risk of drying out. Justin Touchon, post-doctoral fellow at ... Panama may be altering frogs, course of evolution. By analyzing ...
Cached Biology News:Peer review option proposed for biodiversity data 2National Heart Centre Singapore develops world's first human heart cell model 2National Heart Centre Singapore develops world's first human heart cell model 3
... raised against a partial recombinant ... PPP4C (NP_002711, 218 a.a. ... protein with GST tag. ... NM_002720 Protein ...
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
Biology Products: